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Mercury (Hg) is a heavy metal element widely 
distributed in the earth’s crust, seawater, fresh-
water, and air (Environment Canada 2004). 
Concomitantly with modern industrialization, 
human exposure to mercury has increased 
through anthropogenic mercury emissions 
from fuel combustion, municipal incinerators, 
and chemical industries. Mercury is considered 
a major environmental toxicant throughout 
the world (Agency for Toxic Substances and 
Disease Registry 2007; Mahaffey and Mergler 
1998; Salonen et al. 2000; Valera et al. 2008), 
and much effort is being directed toward 
reducing environmental mercury pollution 
(Trasande et al. 2005). In a study of New York 
City adults, the mean blood mercury level was 
2.73 µg/L, higher than blood lead or cadmium 
levels (McKelvey et al. 2007). Moreover, in 
that study, consumers of high-fish diets 
exhibited 3.7 times the blood mercury levels 
observed in those who reported consuming 
no fish. In another study, Akagi et al. (1995) 
reported that some people living in areas 
active in gold mining showed an extremely 
high level of blood mercury, close to 150 µg/L 
(~ 0.75 µM), raising a strong concern over the 
mercury exposure problem. 
Mercury is harmless in insoluble form, 
but vapor or soluble forms such as inorganic 
mercury or methylmercury can be extremely 
toxic to humans. Most human mercury expo-
sure occurs through inhalation of elemental 
mercury vapor released from dental amalgam 
and through the consumption of fish con-
taminated with methylmercury (Berlin et al. 
2007). Once inhaled, elemental mercury 
vapor is rapidly accumulated into erythro-
cytes and undergoes oxidation to the mercu-
ric ion (Hg2+) by catalase. Orally absorbed 
methyl  mercury is preferentially distributed 
into erythrocytes (~ 90%) and slowly turns 
into Hg2+ through demethylation in the 
spleen and liver. It has been demonstrated 
that 6–15% of total mercury in the blood of 
populations consuming high-fish diets exists 
in the form of inorganic mercury (Berglund 
et al. 2005; Rodrigues et al. 2010). Because 
elemental mercury or methylmercury ulti-
mately turns into Hg2+ in the body (Zalups 
2000), mercuric salt has been commonly used 
to investigate the toxicity of mercury.
Mercury toxicity manifests mainly as neu-
ronal dis  orders, immuno  toxicity, and kid-
ney damage (Clarkson et al. 2003); however, 
cardio  vascular diseases (CVDs), including 
athero  sclerosis, coronary heart diseases, pul-
monary embolism, hypertension, and vessel 
obstruction, have been frequently described in 
relation to mercury exposure (Houston 2007; 
Virtanen et al. 2005, 2007). Previously, CVDs 
associated with mercury exposure have been 
assumed to occur as a consequence of renal 
effects of mercury, but increasing attention is 
also being given to direct effects of mercury on 
cardiovascular (CV) tissues, including blood 
vessels, endothelial cells (Wiggers et al. 2008), 
platelets (Macfarlane 1981), and erythrocytes 
(Suwalsky et al. 2000). However, the role of 
direct toxic effects of mercury on CV tissues in 
the pathogenesis of mercury-associated CVDs 
has not been clarified. 
Well-characterized hemolytic and ane-
mia-inducing effects of mercury suggest that 
the erythrocyte might be an important tar-
get of mercury (Zolla et al. 1997). Eisele et al. 
(2006) reported that low-level Hg2+ exposure 
can induce phosphatidyl  serine (PS) transloca-
tion to the external surface of the erythrocyte 
cell membrane (i.e., PS exposure) through the 
modulation of a clotrimazole-sensitive potas-
sium ion (K+) channel. These authors described 
the PS-exposing effects of Hg2+ in relation to 
the apoptosis of erythrocytes. However, the 
implications of PS-externalized erythrocytes in 
pro  coagulant activation and subsequent CVDs 
were not addressed. In another study, altera-
tions of the erythro  cyte membrane, includ-
ing PS exposure and PS-bearing micro  vesicle 
(MV) formation, were reported to be able to 
render erythro  cytes procoagulant, enabling the 
active participation of erythro  cytes in throm-
bosis (Chung et al. 2007). PS exposed on the 
surface of erythrocytes provides a site for the 
assembly of the pro  thrombinase and tenase 
complex, leading to efficient thrombin genera-
tion and ultimately to clotting (Zwaal et al. 
1977; Zwaal and Schroit 1997). Furthermore, 
increased adhesion of PS-expressing erythro-
cytes to endothelial cells contributes to vaso-
occlusion (Closse et al. 1999). MVs generated 
from deformed erythro  cytes through vesicula-
tion also contribute to an acceleration of the 
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Ba c k g r o u n d: Associations between cardiovascular diseases and mercury have been frequently 
described, but underlying mechanisms are poorly understood.
oBjectives: We investigate the procoagulant activation of erythrocytes, an important contributor 
to thrombosis, by low-level mercury to explore the roles of erythrocytes in mercury-related cardio-
vascular diseases.
Me t h o d s : We used freshly isolated human erythrocytes and ex vivo and in vivo thrombosis models 
in rats to investigate mercury-induced procoagulant activity.
re s u l t s: Prolonged exposure to low-dose mercuric ion (Hg2+; 0.25–5 µM for 1–48 hr) induced 
erythrocyte shape changes from discocytes to echinocytes to spherocytes, accompanied by micro-
vesicle (MV) generation. These MVs and remnant erythrocytes expressed phosphatidylserine (PS), 
an important mediator of procoagulant activation. Hg2+ inhibited flippase, an enzyme that recovers 
PS into the inner leaflet of the cell membrane, and activated scramblase, an enzyme that alters lipid 
asymmetry in the cell membrane. Consistent with these activity changes, Hg2+ increased intra-
cellular calcium and depleted ATP and protein thiol. A thiol supplement reversed Hg2+-induced 
MV generation and PS exposure and inhibited the increase in calcium ion (Ca2+) and depletion of 
ATP, indicating that free-thiol depletion was critical to Hg2+-mediated procoagulant activity. The 
procoagulant activity of Hg2+-treated erythrocytes was demonstrated by increased thrombin genera-
tion and endothelial cell adhesion. We further confirmed Hg2+-mediated procoagulant activation of 
erythrocytes in ex vivo and in vivo rat thrombosis models, where Hg2+ treatment (0.5–2.5 mg/kg) 
increased PS exposure and thrombus formation significantly.
co n c l u s i o n: This study demonstrated that mercury could provoke procoagulant activity in 
erythro  cytes through protein-thiol depletion–mediated PS exposure and MV generation, ultimately 
leading to enhanced thrombosis.
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coagulation cascade via strong procoagulant 
activity and by serving as a rich source of PS 
(Martinez et al. 2005).
In the present study, we discovered that 
both MV generation and PS exposure could 
be induced in human erythrocytes by low-
dose Hg2+ (HgCl2, 0.25–5 µM). Of note, 
Hg2+-mediated PS exposure and MV genera-
tion could enhance thrombin genera  tion and 
adhesion to vascular endothelial cells, which 
is considered a direct marker for procoagulant 
activity. We examined the mechanism under-
lying, and in vivo relevancy of, Hg2+-induced 
procoagulant activation of erythro  cytes in an 
effort to gain insight into the CVDs associated 
with mercury exposure.
Materials and Methods
Materials. We purchased mercury chloride 
(HgCl2), calcium chloride (CaCl2), EDTA, 
bovine serum albumin (BSA), KH2PO4, NaCl, 
Na2HPO4, KCl, Tris/HCl, MgCl2, NaH2PO4, 
dextrose, sodium citrate, Tris-base, NaHCO3, 
dimethyl sulfoxide, ethanol, Triton X-100, 
trichloro  acetic acid, Tris-acetate, ATP bio-
luminescent assay kit, iodoacetic acid, adeno-
sine, ethylene glycol tetraacetic acid (EGTA), 
acetic acid, purified human thrombin, and cal-
cium ionophore A23187 from Sigma Chemical 
Co. (St. Louis, MO, USA). Other chemicals 
were of the highest grade available. 
Preparation of human erythrocytes. This 
study was approved by the Institutional Review 
Board at the Seoul National University/Health 
Service Center, and all subjects provided writ-
ten informed consent. On the day of each 
experiment, human blood was obtained from 
healthy male donors (18–25 years of age) into 
Vacutainers containing acid citrate dextrose 
(Becton Dickinson, San Diego, CA, USA). 
Platelet-rich plasma and buffy coat were 
removed by aspiration after centrifugation at 
200 × g for 15 min. Packed erythrocytes were 
washed three times with phosphate-buffered 
saline (PBS; 1 mM KH2PO4, 154 mM NaCl, 
3 mM Na2HPO4, pH 7.4) and once with Tris 
buffer (15 mM Tris-HCl, 150 mM NaCl, 
5 mM KCl, 2 mM MgCl2, pH 7.4) or Ringer 
solution (125 mM NaCl, 5 mM KCl, 1 mM 
MgSO4, 32 mM HEPES, 5 mM glucose, 
pH 7.4). Washed erythrocytes were resus-
pended in Tris buffer or Ringer solution to 
a cell concentration of 5 × 107 cells/mL, and 
the final CaCl2 concentration was adjusted to 
1 mM before use.
Microscopic observation using scanning 
electron microscopy and confocal microscopy. 
After fixation with 2% glutaraldehyde solu-
tion for 1 hr at 4°C, the erythrocytes were cen-
trifuged and washed three times with PBS, 
followed by post  fixation with 1% osmium tet-
roxide for 30 min at room tempera  ture. After 
washing with PBS several times, the samples 
were dehydrated serially with 50%, 75%, 90%, 
and 100% ethanol. After drying and coating 
with gold, the images were observed on a scan-
ning electron microscope (SEM; JEOL, Tokyo, 
Japan). For confocal microscopy, 200 µL eryth-
rocyte suspension was added and attached for 
1 hr to an eight-chambered coverslip (Lab-Tek; 
Nalge Nunc Inc., Naperville, IL) that had been 
coated with 0.1 mg/mL poly-l-lysine. After 
washing the coverslip three times with Tris-
buffered saline (TBS) containing 2% BSA, 
erythrocytes were stained with TBS buffer con-
taining anti–glycophorin-A–FITC for 30 min 
and washed three times again. Erythrocytes 
were then incubated with vehicle (TBS) or 
Hg2+ and observed using confocal microscopy 
equipped with an argon laser (Leica, Wetzlar, 
Germany). Excitation and emission filters were 
set at 488 nm and 550–600 nm, respectively.
Flow cytometric analysis of PS exposure 
and cytosolic calcium in erythrocytes. We used 
fluorescein isothiocyanate (FITC)-labeled 
annexin V (annexin V-FITC; Pharmingen, 
San Diego, CA, USA) as a marker for PS 
positivity and phycoerythrin-labeled mono-
clonal antibody against human glycophorin A 
(anti-glycophorin A–RPE; Dako Cytomation, 
Glostrub, Denmark) to identify erythro  cytes. 
Negative controls for annexin V binding were 
stained with annexin V-FITC in the presence 
of 2.5 mM EDTA instead of 2.5 mM CaCl2. 
For detection of intra  cellular calcium increase, 
erythrocytes were loaded with 3 µM Fluo-
4-AM (Molecular Probes, Eugene, OR, USA) 
for 1 hr at 37°C in the dark. Subsequently, the 
cells were washed twice and then resuspended 
in Tris buffer to a final concentration of 5 × 107 
cells/mL with 1 mM of CaCl2. For the confir-
mation of interference of Fluo-4 calcium signal 
by Hg2+, N,N,N´,N-tetrakis(2-pyridylmethyl)
ethylene  diamine (TPEN; 100 µM; Sigma 
Chemical Co.) was added for 5 min to extract 
Fluo-4–bound Hg2+. To quench extra  cellular 
calcium, 3 mM EGTA was added to the eryth-
rocyte suspension. Samples were analyzed 
on a FACScalibur flow cytometer (Becton 
Dickinson). Data from 10,000 events were 
collected and analyzed using CellQuest Pro 
software (Becton Dickinson). 
Phospholipid translocation measure-
ment. We measured phospholipid transloca-
tion according to the method described by 
Hilarius et al. (2004). Briefly, erythrocytes 
(5 × 107 cells/mL) were incubated with Hg2+ 
and then loaded with 0.5 µM 1-Palmitoyl-2-
[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]
hexanoyl]-sn-glycero-3-phospho-l-serine 
(C6-NBD-PS; Avanti Polar Lipids, Alabaster, 
AL, USA) for the flippase activity assay or 
1-oleoyl-2-[6-[(7-nitro-2–1,3-benzoxadiazol-
4-yl)amino]hexanoyl]-sn-glycero-3-phospho-
choline (C6-NBD-PC; Avanti Polar Lipids) 
for the scramblase activity assay. Aliquots of 
cell suspension were removed at the indicated 
time intervals, placed in cold Tris buffer, and 
incubated on ice for 10 min in the presence 
or absence of 1% BSA. The amount of inter-
nalized probe was determined by comparing 
the fluorescence intensity associated with the 
cells before and after back-extraction by BSA. 
Samples were analyzed on the FACScalibur 
flow cytometer.
Intracellular ATP level measurement. 
After incubation with Hg2+, erythrocytes were 
washed and resuspended in Tris buffer con-
taining 1 mM CaCl2. The aliquot was mixed 
vigorously with 10% trichloroacetic acid solu-
tion and TAE buffer (100 mM Tris-acetate, 
2 mM EDTA, pH 7.8) and then cooled on ice 
for 20 min. The sample was centrifuged, and 
the aliquot of resultant supernatant was mixed 
with cold TAE buffer. Samples were adapted to 
the luciferin/luciferase assay in a Luminoskan 
microplate reader (Labsystems, Franklin, MA, 
USA) using an ATP assay kit (Sigma). We cal-
culated the ATP concentrations based on the 
ATP standard curve.
Protein thiol level measurement. We 
determined protein thiol concentrations using 
a modified assay based on the colorimetric 
method described by Di Monte et al. (1984). 
After incubation with various concentrations 
of Hg2+, erythrocytes were centrifuged at 
7,000 × g for 1 min, and the supernatant was 
removed. The pellet was resuspended with 
lysis buffer (5 mM sodium phosphate, pH 8) 
and incubated on ice for 30 min. Total lysate 
was resuspended with 5% perchloric acid 2:5 
and then centrifuged at 7,000 × g for 2 min. 
The pellet was solubilized in 1 mL Tris-EDTA 
buffer (0.5 mM Tris-HCl, 5 mM EDTA, 
pH 7.6) containing 1% sodium dodecyl sul-
fate. 5,5´-Dithio-bis-(2-nitrobenzoic acid) 
(DTNB; 250 µM) was added to the samples, 
and the change of absorbance was measured 
at 412 nm. The content of protein thiol was 
calculated on the basis of a glutathione calibra-
tion curve and divided by the protein content, 
which was measured by Bio-Rad protein assay 
kit (Bio-Rad, Hercules, CA, USA).
Prothrombinase assay. After incubation 
with Hg2+ for 4 hr, erythrocytes were incu-
bated with 5 nM factor Xa and 10 nM fac-
tor Va (both from Hematologic Technologies 
Inc., Essex Junction, VT, USA) in Tyrode buf-
fer (134 mM NaCl, 10 mM HEPES, 5 mM 
glucose, 2.9 mM KCl, 1 mM MgCl2, 12 mM 
NaHCO3, 0.34 mM Na2HPO4, 0.3% BSA, 
2 mM CaCl2, pH 7.4) for 3 min at 37°C. 
Thrombin formation was initiated by add-
ing 2 µM prothrombin. Exactly 3 min after 
addition of prothrombin, an aliquot of the 
suspension was transferred to a tube contain-
ing stop buffer (50 mM Tris-HCl, 120 mM 
NaCl, 2 mM EDTA, pH 7.9). Thrombin 
activity was determined using the chromoge-
nic substrate S2238 (chromogenic substrate 
for thrombin; Chromogenix, Milano, Italy). 
We calculated the rate of thrombin formation Lim et al.
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from the change in absorbance at 405 nm 
using a calibration curve generated with active-
site–titrated thrombin.
Measurement of thrombin generation 
in plasma. We measured thrombin gen-
eration in plasma according to the method 
described by Peyrou et al. (1999). Briefly, 
Tris buffer- or Hg2+-treated erythrocytes 
were added to plasma, and under gentle 
magnetic stirring, thrombin formation was 
initiated by adding human recombinant tis-
sue factor (Recombiplastin; Instrumentation 
Laboratory, Lexington, MA, USA) diluted 
(1:3,200) in Tris buffer containing 100 mM 
CaCl2 to the mixture. After 10 min, the ali-
quots were collected and transferred to Tris 
buffer containing 20 mM EDTA. The throm-
bin concentration was obtained as described 
above for the prothrombinase assay.
Adherence of erythrocytes to human umbil-
ical vein endothelial cells (HUVEC). The 
HUVEC (three passages) were maintained 
in EGM (endothelial cell growth media)
kit (Clonetics, Walkersville, MD) at 37°C 
Figure 1. Effects of mercury on erythrocytes. (A) Photomicrographs showing shape changes in human erythrocytes incubated with 5 µM Hg2+ up to 4 hr at 37°C, 
fixed, and examined under SEM. Photomicrographs represent three independent experiments from different blood donors; bars = 5 µm. Arrows indicate echino-
cytes, and the arrowhead indicates spherocyte. (B) Photomicrographs of erythrocytes attached to poly-l-lysine–coated coverslip chambers, treated with TBS 
(control; left) or Hg2+ (5 µM; right) for 1 hr, and observed under confocal microscopy using erythrocyte-specific anti–glycophorin-A–FITC. Arrows indicate MV 
generation on erythrocyte membranes. (C) Forward scatter characteristics (FSC) versus side scatter characteristics (SSC) of erythrocytes incubated with distilled 
water (control) or Hg2+ for 4 hr at 37°C; erythrocytes and MV were identified in a representative dot plot (Hg2+ 5 µM). Time-dependent (D) and concentration-depen-
dent (E) increases in MV generation in erythrocytes after Hg2+ incubation. Values are mean ± SE of three to five independent experiments. 
*p < 0.05 compared with control. 
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in a 95% air/5% CO2 incubator. Before the 
experiments, 1 × 105 cells were seeded into a 
T25 flask and grown for 5 days. Erythrocyte 
adherence to HUVEC was meas  ured using 
a modification of the method described by 
Chung et al. (2007). PBS- or Hg2+-treated 
erythrocytes were washed twice and resus-
pended in endothelial basal medium (EBM)-2 
(Clonetics) to a cell concentration of 5 × 107 
cells/mL. After HUVEC were washed twice 
with EBM-2 to remove media, the erythro-
cytes were layered onto a confluent HUVEC 
monolayer and incubated for 45 min at 37°C. 
After the incubation, the flask was rinsed three 
times with EBM-2 to remove non  adherent 
erythrocytes. The number of adherent erythro-
cytes was counted on a light microscope. The 
experiments were performed in triplicate, and 
28 fields were selected randomly for counting 
erythrocytes. 
Ex vivo PS exposure measurement and 
venous thrombosis animal model. We used male 
Sprague-Dawley rats (SamTako Co., Osan, 
Korea) weighing 180–250 g for animal studies. 
For the measurement of PS exposure, animals 
were injected intra  venously with saline (vehi-
cle) or HgCl2 (bolus, 1.0 and 2.5 mg/kg/0.3 
mL) into a left femoral vein; 1 hr later blood 
was collected from the abdominal aorta using 
3.8% trisodium citrate as anticoagulant. An ali-
quot of the blood sample was diluted 200-fold 
with buffer (10 mM HEPES-Na, 136 mM 
NaCl, 2.7 mM KCl, 2.0 mM MgCl2, 1.0 mM 
NaH2PO4, 5.0 mM dextrose, 5 mg/mL BSA, 
2.5 mM CaCl2, pH 7.4) and stained with 
annexin V-FITC for 15 min in the dark. PS 
exposure was measured as described above.
Venous thrombosis was induced by stasis 
combined with hyper  coagulability. Rats (180–
250 g body weight) were anesthetized with 
intraperitoneal urethane (1.25 g/kg), the abdo-
men was surgically opened, and the vena cava 
was exposed. Two loose cotton threads were 
prepared around the vena cava 16 mm apart, 
and all side branches were ligated tightly with 
cotton threads. One hour after intravenous 
injection of saline or HgCl2 (bolus, 0.25, 0.5, 
or 1.0 mg/kg/0.3 mL) into a left femoral vein, 
1,000-fold diluted thrombo  plastin was infused 
to induce thrombus formation. Stasis was ini-
tiated by tightening the two threads, first the 
proximal one, and 30 sec later the distal one. 
The abdominal cavity was provisionally closed, 
and blood stasis was maintained for 15 min. 
After the abdomen was reopened, the ligated 
venous segment was excised and opened lon-
gitudinally to remove the thrombus. The iso-
lated thrombus was blotted of excess blood 
and immediately weighed.
Statistical analysis. We calculated 
mean ± SE for all treatment groups. The data 
were subjected to one-way analysis of vari-
ance followed by Duncan’s multiple range test 
to determine which means were significantly 
different from control. In all cases, p < 0.05 
indicated significance.
Results
To investigate the effects of mercury on 
erythro  cytes, we examined the shape change 
in erythrocytes after exposure to 5 µM HgCl2 
using SEM. As shown in Figure 1A, normal 
discocytic shapes changed into echino  cytic 
erythrocytes and further into sphero  cytes, 
depending on the length of exposure to Hg2+. 
It is well known that erythrocytes change into 
spherocytes by a substantial loss of membrane 
surface through vesiculation and MV gen-
eration. To visually identify MV generation, 
we treated erythrocytes attached to a poly-l-
lysine–coated coverslip chamber with Hg2+ 
and observed them under confocal microscopy 
using erythrocyte-specific anti–glycophorin-
A–FITC. Hg2+ treatment induced typical 
MV generation on erythrocyte membranes 
(Figure 1B, right). In flow cytometry analy-
sis, MV generation increased in a time- and 
concentration-dependent manner after Hg2+ 
incubation (Figure 1C,D).
MVs bearing PS can display procoagu-
lant activity. In the flow cytometry analy-
sis with annexin V-FITC to specifically 
detect PS, MVs generated by Hg2+ treat-
ment expressed PS in their outer membranes 
(Figure 2A). Moreover, remnant erythrocytes 
also expressed PS in the outer membrane 
Figure 2. Effects of Hg2+ on PS exposure in MV and remnant erythrocytes and on aminophospholipid translocation. Human erythro  cytes were incubated with 
distilled water (control) or Hg2+ at 37°C, and flow cytometric analysis was performed. (A) Representative histogram of remnant cells (top) and MVs (bottom) 
expressing PS, with annexin-V as a marker of PS positivity. (B, C) Time- and concentration-dependent effects of Hg2+ on PS exposure on erythrocytes incubated 
with distilled water (control) or 1, 2, or 5 µM Hg2+ for 1 hr at 37°C (B) or at varied Hg2+ doses for 24 or 48 hr (C). C6-NBD-PS (PS) translocation by flippase (D) and 
C6-NBD-PC (PC) translocation by scramblase (E). Values are mean ± SE of three independent experiments. 
*p < 0.05 compared with control. 
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(62.2 ± 11.2% at 5 µM Hg2+; Figure 2B), 
consistent with the report by Eisele et al. 
(2006). PS expression also increased in a time-
dependent manner with Hg2+ (Figure 2B, 
inset), and of particular note, prolonged 
exposure induced significant PS expression 
even at lower concentrations of Hg2+ (down 
to 0.25 µM; Figure 2C). To investigate the 
mechanism underlying Hg2+-induced PS 
exposure and MV generation, we evaluated the 
activities of representative amino  phospho  lipid 
trans  locases governing lipid asymmetry. We 
measured flippase, an enzyme that recovers 
PS into the inner leaflet of the cell membrane, 
and scramblase, an enzyme that disrupts lipid 
asymmetry in the cell membrane, based on 
the extent of C6-NBD-PS and C6-NBD-PC 
translocation, respectively, after incubation of 
Hg2+. C6-NBD-PS and C6-NBD-PC are the 
fluorescent analogs of PS and phos  phatidyl-
choline; we meas  ured the internalization of 
C6-NBD-PS and C6-NBD-PC by flippase 
and scramblase, respectively, by comparing 
the fluorescence intensity associated with the 
cells before and after BSA back-extraction, 
as described in “Materials and Methods.” As 
shown in Figure 2D and E, flippase was inhib-
ited by Hg2+, whereas scramblase was activated 
in a concentration-dependent manner, which 
explains Hg2+-induced PS exposure.
Increased intracellular calcium can mediate 
concomitant inhibition of flippase and activa-
tion of scramblase, leading to the disruption of 
membrane lipid asymmetry (Daleke 2003). To 
investigate whether Hg2+ treatment can induce 
calcium increase, we incubated Fluo-4–loaded 
Figure 3. Effects of Hg2+ on intracellular Ca2+ ATP, and protein thiol in human erythrocytes. (A) Intracellular Ca2+ levels {[Ca2+]i}, in erythrocytes loaded with Fluo-4, 
incubated with distilled water (control) or 1, 2, or 5 µM Hg2+ 4 hr at 37°C, and evaluated by flow cytometry; 100 µM TPEN was used to exclude interference from 
intracellular Hg2+. (B) ATP level in erythrocytes incubated with distilled water (control) or 1, 2, or 5 µM Hg2+ for 4 hr at 37°C, and measured by a bioluminescent 
assay. PS exposure (C) and MV generation (D) measured by flow cytometry analysis in human erythrocytes pretreated with 0.5 mM N-acetylcysteine (NAC), 
0.5 mM DTT (thiol supplements), or 100 µM Trolox (antioxidant) 5 min before treatment with 5 µM Hg2+. (E) Protein thiol measured using the DTNB method. 
(F) Inhibition of Ca2+ increase (left) and ATP depletion (right) by thiol supplements. Values are mean ± SE of three independent experiments. 
*p < 0.05 compared with control. #p < 0.05 compared with Hg2+ treatment alone.
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Figure 4. Enhancement of thrombin generation and erythrocyte adherence to endothelial cells by Hg2+ treatment. (A) Erythrocytes (red blood cells, RBCs) were 
incubated with distilled water (control) or 1, 2, or 5 µM Hg2+ for 4 hr at 37°C, and aliquots were subjected to the prothrombinase assay. (B) Hg2+-treated erythro-
cytes were added to human plasma, and thrombin generation was initiated by Recombiplastin. (C) Hg2+-treated erythro  cytes were incubated with HUVECs for 
45 min; after washing, erythrocytes adhered to HUVECs were counted under a microscope. Values are mean ± SE of three to five independent experiments. 
*p < 0.05 compared with control. 
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erythrocytes with Hg2+ and meas  ured intra-
cellular calcium increase by flow cytometry 
analysis. As shown in Figure 3A, Hg2+ treat-
ment increased intra  cellular calcium promi-
nently, up to 10 times the basal level. For this 
calcium signal, an artifactual increase due to 
possible interference with Fluo-4 binding by 
Hg2+ could be excluded by adding the Hg2+ 
quencher TPEN, a high-affinity membrane- 
permeable intra  cellular heavy metal chela-
tor (Arslan et al. 1985). ATP depletion, 
which can prompt flippase inhibition, was 
also induced by Hg2+ (Figure 3B). In gen-
eral, Hg2+-induced cyto  toxicity is mediated 
by thiol depletion (Zalups 2000) or oxida-
tive stress (Wiggers et al. 2008). To examine 
the role of thiol depletion and oxidative stress 
in Hg2+-induced PS exposure and MV gen-
eration, we pre  incubated erythrocytes with the 
thiol supplements N-acetylcysteine and dithio-
threitol (DTT) or the antioxidant Trolox. As 
shown in Figure 3C, Trolox was marginally 
effective, whereas thiol supplements effectively 
blocked Hg2+-induced PS exposure and MV 
generation, indicating a major role of thiol 
depletion. Indeed, Hg2+ treatment induced 
significant thiol depletion (Figure 3E). In 
line with these findings, thiol supplementa-
tion prevented Hg2+-induced ATP depletion 
and Ca2+ increase (Figure 3F), indicating that 
Hg2+ induces PS exposure and MV gener-
ation in erythrocytes through protein-thiol 
depletion–mediated ATP depletion and 
Ca2+ increases.
We confirmed prothrombotic effects of 
Hg2+-induced PS exposure and MV gen-
eration by evidence of increased thrombin 
generation based on the prothrombinase 
assay and thrombin generation in plasma 
(Figure 4A,B). Moreover, we demonstrated 
increased adherence of Hg2+-exposed eryth-
rocytes to endothelial cells by increased eryth-
rocyte adhesion on HUVEC (Figure 4C). 
To evaluate the in vivo relevance of Hg2+-
induced procoagulant activity in erythrocytes, 
we used rat ex vivo PS exposure measurement 
and in vivo venous thrombosis models. Before 
the in vivo experiments, we confirmed PS 
exposure and MV generation by Hg2+ in rat 
erythro  cytes (Figure 5A), which showed a 
pattern similar to that of human erythrocytes. 
Confirming these in vitro results, treatment 
of HgCl2 [intravenous bolus 0.25–2.5 mg/
kg (0.92–9.2 µmol/kg)] induced PS expo-
sure on erythrocytes ex vivo (Figure 5B; 
2.1 ± 0.2% for 1 mg/kg and 3.4 ± 0.7% for 
2.5 mg/kg HgCl2 vs. 1.4 ± 0.1% for vehicle; 
p < 0.05) and promoted clot formation in a 
stasis- and hypercoagulability-induced venous 
thrombosis model after thromboplastin infu-
sion (Figure 5C; 12.2 ± 1.0 mg for 0.5 mg/
kg HgCl2 and 16.9 ± 2.3 mg for 1 mg/kg 
HgCl2 vs. 2.4 ± 1.7 mg for vehicle; p < 0.01), 
suggesting that Hg2+-induced procoagulant 
activity in erythrocytes could contribute to 
increased thrombosis in vivo.
Discussion
In this study, we demonstrated that Hg2+ can 
induce shape changes, MV generation, and PS 
exposure on erythrocytes, important media-
tors of procoagulant activation of erythrocytes. 
Hg2+-mediated thiol depletion was responsible 
for calcium increase–mediated and ATP deple-
tion–mediated flippase inhibition and scram-
blase activation, leading to increased thrombin 
generation, enhanced adhesion of erythrocytes 
to endothelial cells, and ultimately, acceler-
ated thrombus formation (Figure 6). Of par-
ticular note, ex vivo PS exposure measurement 
and the rat in vivo venous thrombosis model 
confirmed the procoagulant effect of Hg2+ 
by demonstrating increased PS exposure and 
clot formation, suggesting that procoagulant 
activation of erythrocytes might contribute to 
CVDs associated with mercury exposure.
Erythrocytes can contribute to hemo-
stasis and thrombosis through procoagulant 
activation via PS exposure and MV genera-
tion (Zwaal et al. 2005; Zwaal and Schroit 
1997). Endogenous thrombogenic sub-
stances such as arachidonic acid, lysophos-
phatidic acid, and thromboxane are known 
to induce PS exposure on erythrocyte sur-
faces (Chung et al. 2007; Valles et al. 2002). 
In addition, we previously demonstrated that 
Figure 5. Effects of Hg2+ on PS exposure and thrombus formation in an in vivo 
rat model. (A) MV generation and PS exposure in rat erythrocytes (red blood 
cells, RBCs) treated with distilled water (control) or 1, 2, or 5 µM Hg2+ for 4 hr at 
37°C and measured by flow cytometry. Extent of PS exposure on erythrocytes 
measured in whole blood using flow cytometry (B), and thrombus formation 
induced by the infusion of thromboplastin (C) in rats administered intra  venous 
saline (control) or HgCl2 (0.25–2.5 mg/kg). Values are the mean ± SE of four 
independent experiments. 
*p < 0.05 compared with control. 
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Figure 6. Suggested mechanism of Hg2+-induced procoagulant activation 
of erythrocytes. Hg2+ induces procoagulant activation of erythrocytes and 
enhanced thrombus formation through thrombogenic PS exposure and 
MV generation mediated by protein thiol depletion, ATP depletion, and Ca2+ 
increase via scramblase activation and flippase inhibition. Abbreviations: 
EC, endothelial cell; RBC, red blood cells (erythrocytes); SMC, smooth 
muscle cell. Lim et al.
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lead, another toxic heavy metal, can induce a   
substantial level of PS exposure in erythrocytes 
and that this procoagu  lant activity manifested 
as enhanced thrombus formation (Shin et al. 
2007). Interestingly, it is well known that 
erythrocytes can be a preferential store for toxic 
heavy metals. Methylmercury accumulates in 
erythrocytes at a concentration > 20 times that 
of plasma (Clarkson 2002), and 90% of body 
lead is associated with erythro  cytes. These find-
ings suggest that erythrocytes can be a common 
target for CV toxicity of heavy metals; thus, 
the role of erythrocytes in CV toxicity of heavy 
metals should be more closely investigated.
Milli  molar concentrations of Hg2+ have 
been reported to induce shape changes and 
hemolysis in erythrocytes (Suwalsky et al. 
2000; Zolla et al. 1997). The concentration 
employed in those studies, however, was 
unrealis  tically high, considering reported 
human exposure levels even in highly contam-
inated areas. In the present study, however, 
we discovered that longer exposure to concen-
trations of Hg2+ as low as 0.25 µM can induce 
shape changes and procoagulant activation in 
erythrocytes as determined by increased PS 
exposure. The highest blood mercury concen-
trations reported in humans were in workers 
in the gold mines of the Amazon area (Akagi 
et al. 1995), whose blood mercury levels were 
as high as 150 µg/L (~ 0.75 µM). Wierzbicki 
et al. (2002) reported that workers occupa-
tionally exposed to mercuric vapors exhib-
ited a statistically significant increase in blood 
coagulation along with increased thrombin 
generation. Their average plasma mercury lev-
els were approximately 0.03–0.04 µM but 
measured as high as 83.3 µg/L (0.4 µM). 
Virtanen et al. (2005) observed increased 
CV events in a mercury-exposed population 
with an average hair mercury level of 1.9 µg/g 
(0–15.7 µg/g), which is estimated to indicate 
a blood mercury level of 9.5 µg/L (0.05 µM) 
based on a 200:1 hair-to-blood mercury ratio 
(Budtz-Jorgensen et al. 2004). These levels are 
within an order of magnitude of the mercury 
concentrations used in our study, suggesting 
that mercury-induced procoagulant activation 
of erythrocytes might indeed contribute to 
the increased CVDs in human popu  lations. 
However, because we conducted our study 
with only Hg2+, further in vivo studies 
with methylmercury or elemental mercury 
are needed to fully clarify the link between 
mercury-mediated pro  coagulant activation of 
erythrocytes and mercury-associated CVDs.
Adding to the previous report on Hg2+-
induced echinocytic changes in human eryth-
rocytes (Suwalsky et al. 2000), we found that 
echinocytes can be further progressed into 
spherocytes (Figure 1A) by prolonged exposure 
to Hg2+. Moreover, along with these remark-
able shape changes, substantial numbers of 
MVs can be liberated from erythrocytes. Apart 
from clot-promoting activity in plasma, MV 
generation can result in decreased deformability 
of erythrocytes (Chabanel et al. 1989; Chasis 
and Mohandas 1986; Mentzer et al. 1987) 
and, more important, PS-exposing MVs pro-
vide sites for adhesion of platelets and neutro-
phils by localizing at the sub  endothelium, 
indicating that Hg2+-induced MV generation 
can contribute to the prothrombotic effects of 
mercury exposure.
In our study, we determined thiol deple-
tion to be a key mediator for calcium increase, 
ATP depletion, PS exposure, and MV genera-
tion in erythrocytes by Hg2+. Thiol depletion 
by Hg2+ can be well explained by the strong 
thiol-binding affinity of nucleophilic Hg2+ 
(Casarett et al. 2007). Intracellular mole  cules 
with free sulfhydryl groups, such as gluta-
thione, cysteine, and metallo  thionein, can be 
easy targets for Hg2+ binding, and free thiol 
groups of intra  cellular proteins, which are 
vital to the maintenance of erythro  cyte integ-
rity (e.g., of the cytoskeleton) and ionic bal-
ance (e.g., Na2+/K+-ATPase), can be readily 
modified by thiol-depleting agents, leading to 
a increased fragility of the erythro  cyte mem-
brane and disruption of ionic homeostasis. 
Moreover, depletion of free thiols in cells can 
cause depletion of ATP, inhibition of flip-
pase (Daleke and Lyles 2000), and increased 
calcium, consistent with the result of the 
present study.
Conclusion
We demonstrated that low-dose mercury can 
induce thrombogenic PS exposure and MV 
generation through thiol-depletion–mediated 
ATP depletion and calcium increase in eryth-
rocytes. As shown by increased PS exposure 
and clot formation in vivo, mercury-induced 
procoagulant activation of erythrocytes might 
contribute to enhanced thrombosis in the 
population exposed to mercury, providing 
an important clue for the elucidation for the 
CVDs associated with mercury.
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